| 000 | 00883 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513085730.0 | ||
| 264 | 0 | _c19960502 | |
| 008 | 199605s 0 0 eng d | ||
| 022 | _a0161-6420 | ||
| 024 | 7 |
_a10.1016/s0161-6420(96)38046-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKing, C K | |
| 245 | 0 | 0 |
_aThe CVOS Group M and N reports. _h[electronic resource] |
| 260 |
_bOphthalmology _cMar 1996 |
||
| 300 |
_a352, author reply 353-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comment; Letter; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRetinal Vein _xpathology |
| 650 | 0 | 4 |
_aRetinal Vein Occlusion _xdiagnosis |
| 773 | 0 |
_tOphthalmology _gvol. 103 _gno. 3 _gp. 352, author reply 353-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0161-6420(96)38046-9 _zAvailable from publisher's website |
| 999 |
_c8599457 _d8599457 |
||